Our studies confirmed that LBH589 precluded tumor growth compared to vehicle in three different tumors from women who underwent primary cytoreduction at our institution and suggest only a subset of high grade serous carcinomas will manifest heightened tumor regression if chemotherapy is administered in the setting of tonic HDAC inhibition. Here, HDAC9 is linked to neoplasm.